United States · Federal contract register · Supplier record

RARE DISEASE THERAPEUTICS, INC.

Line: Drugs and biologicals (6505)Register loaded to November 2025Compiled 6 October 2026

RARE DISEASE THERAPEUTICS, INC. — United States · Federal contract register · Supplier record: 47 contracts, all years ($1,382,757 · Oct 2011 – Jun 2026); $276K since January 2024 (9 contracts · 1 agency); 249th rank in the line (of 514 suppliers · 0.0%); 10 agencies never served ($7.6B on the line without RARE DISEASE THERAPEUTICS, INC.).

Assay record ASY-US-1934CQS07I · Cite as: Assay Systems, “RARE DISEASE THERAPEUTICS, INC. in the USAspending register”, https://assay-systems.com/register/us/rare-disease-therapeutics-inc/

47
contracts, all years
$1,382,757 · Oct 2011 – Jun 2026
$276K
since January 2024
9 contracts · 1 agency
249th
rank in the line
of 514 suppliers · 0.0%
10
agencies never served
$7.6B on the line without RARE DISEASE THERAPEUTICS, INC.

Own record by year

2019 onward
$49.0K
$153K
$8.2K
$45.1K
$33.0K
$55.9K
$138K
$82.0K
20192020202120222023202420252026

Who buys from RARE DISEASE THERAPEUTICS, INC.

since January 2024
1agencies
$276Kpaid
100.0%top buyer
Department of Health and Human Services100.0%
$275,558

Before 2024 only: Department of Veterans Affairs, Smithsonian Institution.

The line

since January 2024
$28.2Bline value
158,923contracts
12agencies
514suppliers
96.4%held by top ten

Drugs and biologicals (6505)

$15.1B
$13.2B
20242025
249thof 514 suppliers
$193,558RARE DISEASE THERAPEUTICS, INC. in the line
0.0%share of the line
0.0%of $1,770,840,157 spent by Department of Health and Human Services

Agencies that buy the line and never bought from RARE DISEASE THERAPEUTICS, INC.

10agencies
155,685contracts
$7,565,112,166since January 2024
Department of Defense151,816 contracts
$7,145,190,573
Department of Justice3,446 contracts
$367,934,841
Department of Agriculture21 contracts
$40,416,864
Department of State233 contracts
$8,285,468
Peace Corps158 contracts
$2,977,299
Department of Homeland Security5 contracts
$127,122
Department of the Interior2 contracts
$89,569
Department of the Treasury2 contracts
$50,300
Environmental Protection Agency1 contract
$27,529
Court Services and Offender Supervision Agency1 contract
$12,600

How the line is bought

by value, since 2024
2%no competition
1%one applicant
0of these to RARE DISEASE THERAPEUTICS, INC.
Competed, several suppliers applied155,551 contracts
$27,183,859,346 · 96.4%
Awarded directly, no competition1,494 contracts
$630,079,768 · 2.2%
Competed, one supplier applied1,878 contracts
$393,524,607 · 1.4%

Contracts reaching their end dates

Oct 2026 – October 2027
83contracts
$634,984,156end by October 2027
22end in August 2027 · $39.5M
4in agencies never served · $1.1M
$11.8M
$3.8M
$4.5M
$34.2M
$2.8M
$1.4M
$38.9M
$447M
$1.2M
$39.5M
$49.6M
Oct 2620 contractsNov 269 contractsDec 265 contractsFeb 274 contractsMar 277 contractsApr 273 contractsMay 275 contractsJun 274 contractsJul 272 contractsAug 2722 contractsSep 272 contracts

Suppliers next to it in the line

since January 2024
SKYLINE PHARMACEUTICALS, INC.3 contracts · 1 agency
$195,552
ADC THERAPEUTICS AMERICA, INC.1 contract · 1 agency
$194,000
LANTHEUS BIOSCIENCES LTD.3 contracts · 1 agency
$193,900
RARE DISEASE THERAPEUTICS, INC.
$193,558

All 514 suppliers in the line

Fastest-growing supplier in the line

same line
+97%growth

Supplier UEI KABZK8W6PQT3

2024 to date
$7,051,163,185
2022–2023
$3,579,627,887

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.